J.C. Penney Company Inc (JCP) 8.56 $JCP McDonald's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
J.C. Penney Company Inc (JCP) 8.56 $JCP

McDonald's Corporation Looks More Like This Failing Retailer Every Day
Rich Duprey, The Motley Fool - Motley Fool - 1 hr 30 mins ago
The golden arches have become tarnished in recent years, and now it looks more like a business in serious decline.  One is an aging department store operator and the other a mature hamburger stand, but McDonald's suffers from the same malaise...
SCC: 11.47 (-0.07), AMZN: 389.80 (-1.38), SHAK: 62.00 (+2.00), JCP: 8.56 (-0.02), WMT: 78.43 (+0.40), M: 67.00 (-0.03), HABT: 33.00 (+0.55), MCD: 97.84 (+2.97), LE: 29.96 (-0.13), SHLD: 42.16 (+0.39), SHOS: 7.02 (-0.22)

Be on Top of the Latest Developments: Complementary Research on McDermott, J.C. Penney, Apple, Ford Motor, and Avon
PR Newswire - Wed Apr 22, 6:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AVP: 8.81 (-0.07), F: 15.91 (+0.09), MDR: 4.95 (+0.06), JCP: 8.56 (-0.02), AAPL: 128.62 (+1.71)

3 Reasons JC Penney Company Inc Stock Could Fall
Rich Duprey, The Motley Fool - Motley Fool - Tue Apr 21, 5:29PM CDT
J.C. Penney just cannot catch a break these days. Even when the department store chain surprised analysts last week by "accidentally" releasing better than expected comparable sales, Wall Street attributed the boon to an early Easter in the first...
KSS: 75.91 (+0.96), JCP: 8.56 (-0.02), M: 67.00 (-0.03)

JC Penney (JCP) Approaches New Downside Target of $8.56
Comtex SmarTrend(R) - Tue Apr 21, 12:33PM CDT
JC Penney (NYSE:JCP) has opened bearishly below the pivot of $8.69 today and has reached the first level of support at $8.60. Analysts will be watching for a cross of the next downside pivot targets of $8.56 and $8.43.
JCP: 8.56 (-0.02)

10.8% Return Seen to Date on SmarTrend JC Penney Call (JCP)
Comtex SmarTrend(R) - Tue Apr 21, 10:11AM CDT
SmarTrend identified an Uptrend for JC Penney (NYSE:JCP) on January 7th, 2015 at $7.76. In approximately 3 months, JC Penney has returned 10.82% as of today's recent price of $8.60.
JCP: 8.56 (-0.02)

Critical Alerts For JC Penney, Noodles & Company, CSX, Akamai Technologies and Goodrich Petroleum Corp. Released By InvestorsObserver
PR Newswire - Mon Apr 20, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for JCP, NDLS, CSX, AKAM and GDP.
GDP: 3.58 (-0.10), AKAM: 76.02 (+0.72), NDLS: 19.73 (+0.31), JCP: 8.56 (-0.02), CSX: 36.26 (+0.91)

Oops! J.C. Penney Company Inc. Accidentally Lets Slip It's Having a Great Quarter
Rich Duprey, The Motley Fool - Motley Fool - Sat Apr 18, 4:10PM CDT
The bear case against J.C. Penney is largely predicated on the troubled retailer not being able to repeat the performance it had last year. The smart money said all the easy sales had already been made and now that it was lapping those results,...
JCP: 8.56 (-0.02)

What Everybody Ought to Know: Complementary Research on J. C. Penney Company, CSX Corp, Alcatel-Lucent, Nokia Corporation and Intel Corporation
PR Newswire - Fri Apr 17, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ALU: 4.12 (+0.09), JCP: 8.56 (-0.02), INTC: 32.70 (+0.27), CSX: 36.26 (+0.91), NOK: 8.00 (+0.16)

BUYINS.NET: GLUU, MLNX, CNK, FRI, TTGT, HJV Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Apr 17, 7:00AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Glu Mobile Inc (NASDAQ:GLUU), Mellanox Technologies Ltd (NASDAQ:MLNX), Cinemark Holdings Inc (NYSE:CNK), First Trust S&P REIT Index Fund (NYSE:FRI), TechTarget Inc (NASDAQ:TTGT), MS Structured Asset Corp. SATURNS J.C. Penney Company Inc. Debenture Backed Ser (NYSE:HJV) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
HJV: 17.99 (+0.12), FRI: 22.63 (+0.05), JCP: 8.56 (-0.02), TTGT: 11.26 (-0.13), MLNX: 49.54 (+1.24), GLUU: 5.55 (+0.44), CNK: 42.83 (-0.01)

Is Men's Wearhouse Stock a Buy?
Rich Duprey, The Motley Fool - Motley Fool - Thu Apr 16, 7:00PM CDT
After hitting a 52-week low of just under $40 a share back in December as profits missed forecasts, men's clothing retailer Men's Wearhouse staged a dramatic comeback and its stock has soared 38% since that deep winter freeze. A sharp change in...
COH: 41.59 (+0.10), MW: 56.09 (-0.27), JCP: 8.56 (-0.02)

JCPenney Named One of America's Best Employers for 2015
Thomson Reuters ONE - Thu Apr 16, 3:29PM CDT
PLANO, Texas (April 16, 2015) - J. C. Penney Company, Inc. (NYSE:JCP) was recently named one of America's Best Employers for 2015 according to an independent study organized by Forbes and Statista.com. The survey anonymously questioned 20,000 Americans on whether they would recommend their employer to potential employees, and was conducted through a variety of anonymous online panels.
JCP: 8.56 (-0.02)

JC Penney (JCP) Breaks Through Support at $8.80
Comtex SmarTrend(R) - Thu Apr 16, 12:32PM CDT
JC Penney (NYSE:JCP) has opened bearishly below the pivot of $9.05 today and has reached the first level of support at $8.80. Analysts will be watching for a cross of the next downside pivot targets of $8.68 and $8.31.
JCP: 8.56 (-0.02)

3 Double-Digit Yields In The Red-Hot Retail Sector
Richard Lejeune - at Seeking Alpha - Wed Apr 15, 6:48PM CDT

JCP: 8.56 (-0.02), SHLD: 42.16 (+0.39)

J.C. Penney Discloses Q1 Comps Data After Email SNAFU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 5:15PM CDT
After an executive inadvertently emailed the first-quarter fiscal 2015 comps details to a security analyst, J. C. Penney Company, Inc. (JCP) was forced to make the information public.
EXPR: 17.33 (+0.04), AEO: 16.93 (unch), JCP: 8.56 (-0.02), CTRN: 24.27 (+0.16)

J.C. Penney: Shorting The Common Shares While Long Preferred
Elephant Analytics - at Seeking Alpha - Wed Apr 15, 3:52PM CDT

JCP: 8.56 (-0.02)

Ross Stores Prices Low, Sells More And Expands
at Investor's Business Daily - Wed Apr 15, 12:35PM CDT
At 1,362 units and counting, Ross Stores (ROST) is the largest off-price apparel and home fashion chain in the U.S. Yet it has few stores in the Northeast and none in the dense New York City market. And only in the last few years has it begun opening...
TJX: 66.41 (+0.12), TGT: 81.34 (+0.09), JCP: 8.56 (-0.02), WMT: 78.43 (+0.40), GPS: 40.70 (+0.09), BURL: 55.82 (+0.09), SHLD: 42.16 (+0.39), ROST: 103.90 (+0.28)

J.C. Penney: Q1 2015 Comp Pre-Release Makes Appetite For More
Achilles Research - at Seeking Alpha - Wed Apr 15, 10:06AM CDT

JCP: 8.56 (-0.02)

J.C. Penney Q1 comps leaked
at Investor's Business Daily - Tue Apr 14, 6:04PM CDT
The dept. store chain said in a regulatory filing that a company official accidentally emailed Q1 same-store sales data to an analyst. The email said same-store sales for the April-ending quarter, boosted by the Easter holiday, were up about 6% so...
JCP: 8.56 (-0.02)

Watch for JC Penney to Potentially Rebound After Falling 2.66% Yesterday
Comtex SmarTrend(R) - Tue Apr 14, 4:41PM CDT
JC Penney (NYSE:JCP) traded in a range yesterday that spanned from a low of $9.02 to a high of $9.50. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $9.03 on volume of 20.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JCP: 8.56 (-0.02)

Look for Shares of JC Penney to Potentially Rebound after Yesterday's 2.66% Sell Off
Comtex SmarTrend(R) - Tue Apr 14, 4:40PM CDT
JC Penney (NYSE:JCP) traded in a range yesterday that spanned from a low of $9.02 to a high of $9.50. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $9.03 on volume of 20.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JCP: 8.56 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles